Male infertility is a medical condition in which a man has a reduced ability or inability to cause pregnancy in a fertile female partner. It is commonly caused by issues such as low sperm count, poor sperm motility, abnormal sperm shape, hormonal imbalances, genetic defects, or blockages in the reproductive tract. The primary purpose of addressing male infertility is to identify and treat the underlying causes to improve the chances of natural conception or assist with reproduction through medical interventions.
The male infertility market consists of sales, by entities (organizations, sole traders and partnerships), of male infertility that are used by individuals or couples seeking to conceive, its treatment is sought whenever conception challenges arise, which can be at any age but most commonly in men 30-50 years old.
The global male infertility market was valued at $3,342.35 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 4.00%.
Rising Investments In R&D And Fertility Biotech
During the historic period, the rising investments in R&D and fertility biotech supported the growth of the male infertility market. These investments enabled the development of innovative diagnostic tools, advanced treatment options, and new technologies, helping companies improve success rates, address unmet medical needs, and expand their service offerings. As a result, businesses were able to enhance their competitive advantage, attract more patients, and strengthen their position in the growing fertility sector. For instance, in June 2025, according to the National Institutes of Health (NIH), a US-based government agency, reported that in 2024, the United States allocated $221 million to infertility research, reflecting an increase from the $216 million invested in 2023. Therefore, the rising investments in R&D and fertility biotech drove the growth of the male infertility market.
Advancing Male Infertility Diagnosis Through At-Home Fertility Test
Companies operating in the male infertility market are focusing on developing at-home fertility test for gaining competitive advantage. The at-home fertility test is designed to provide an easier and faster process to traditional fertility testing, a cheaper alternative to specialist appointments and to also alleviate pressure on the National Health Service (NHS). For instance, in June 2023, Newfoundland, a UK-based company specializing in the development and distribution of diagnostic health tests launched the fastest and most affordable at-home fertility test. The new test, which is available over the counter, gives fertility results in just five minutes and boasts 98.2 per cent accuracy. The new at-home Male Fertility test will give men the opportunity to understand more about their fertility and seek the right medical advice if needed.
The global male infertility markets is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 25.54% of the total market in 2024.
Male Infertility Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global male infertility market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for male infertility? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The male infertility market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider male infertility market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by source, by application and by end-user.
- Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Analysis Framework:- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation: - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment source, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market
- Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard: - Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments: - Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for male infertility providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Treatment Type: Medication; Surgery; Assisted Reproductive Technology
- 2) By Test Type: Sperm Agglutination; Deoxyribonucleic Acid Fragmentation Technique; Oxidative Stress Analysis; Computer Assisted Semen Analysis; Sperm Penetration Assay; Other Test Types
- 3) By End-User: Hospitals And Clinics; Fertility Centers; Research Institutes; Other End-Users
- Companies Mentioned: Bayer AG; Merck KGaA / Merck Serono; Zydus Lifesciences; Intas Pharmaceuticals Ltd; CooperSurgical Inc.
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; male infertility indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.